Gross Profit for STERIS (STE)
According to STERIS's latest reported financial statements, the company's current gross profit (TTM) is $2.57B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$2.57B
YoY change
+8.3%
5Y CAGR
+12.7%
Peak year (2025)
$2.40B
Cumulative gross profit
$24.88B
Gross Profit history chart for STERIS (STE) from 1991 to 2025
Gross Profit history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $2.40B | +8.3% | ||
| 2024 | $2.22B | +12.0% | ||
| 2023 | $1.98B | +5.2% | ||
| 2022 | $1.88B | +40.2% | ||
| 2021 | $1.34B | +1.8% | ||
| 2020 | $1.32B | +12.3% | ||
| 2019 | $1.17B | +7.5% | ||
| 2018 | $1.09B | +6.5% | ||
| 2017 | $1.03B | +14.6% | ||
| 2016 | $895.48M | +15.7% | ||
| 2015 | $774.30M | +19.2% | ||
| 2014 | $649.62M | +4.6% | ||
| 2013 | $621.26M | +9.3% | ||
| 2012 | $568.47M | +27.4% | ||
| 2011 | $446.16M | -17.3% | ||
| 2010 | $539.18M | +2.4% | ||
| 2009 | $526.74M | +0.5% | ||
| 2008 | $523.96M | +3.8% | ||
| 2007 | $504.81M | +4.3% | ||
| 2006 | $484.19M | +4.8% | ||
| 2005 | $461.92M | +4.1% | ||
| 2004 | $443.90M | +8.6% | ||
| 2003 | $408.82M | +15.1% | ||
| 2002 | $355.20M | -5.2% | ||
| 2001 | $374.51M | +5.5% | ||
| 2000 | $355.10M | -11.6% | ||
| 1999 | $401.90M | +15.2% | ||
| 1998 | $348.80M | +40.4% | ||
| 1997 | $248.40M | +11.7% | ||
| 1996 | $222.40M | -0.4% | ||
| 1995 | $223.40M | +681.1% | ||
| 1994 | $28.60M | +78.8% | ||
| 1993 | $16.00M | +119.2% | ||
| 1992 | $7.30M | +35.2% | ||
| 1991 | $5.40M | — |
Gross Profit values are taken from STERIS's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual gross profit for STERIS (STE) came in at $2.40B – grew 8.3% year-over-year.
Across 2020–2025 (5 years), STERIS gross profit produced a CAGR of +12.7% – sustaining 14 straight years of year-over-year growth.
The highest annual gross profit of $2.40B was reported in 2025. The lowest in the available history was $5.40M in 1991.
Among 8 Healthcare peers, STERIS (STE) ranks 9th; the peer median for gross profit is $53.80B.
STERIS Gross Profit by Year
STERIS Gross Profit 2025: $2.40B
STERIS gross profit in 2025 was $2.40B, grew 8.3% from 2024. This figure represents the highest annual value in the available history.
STERIS Gross Profit 2024: $2.22B
STERIS gross profit in 2024 was $2.22B, grew 12.0% from 2023.
STERIS Gross Profit 2023: $1.98B
STERIS gross profit in 2023 was $1.98B, grew 5.2% from 2022.
STERIS Gross Profit 2022: $1.88B
STERIS gross profit in 2022 was $1.88B, surged 40.2% from 2021.
STERIS Gross Profit 2021: $1.34B
STERIS gross profit in 2021 was $1.34B.
See more financial history for STERIS (STE).
Sector peers — Gross Profit
Companies in the same sector as STERIS, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is STERIS's gross profit?
- Latest reported gross profit for STERIS (STE) is $2.57B (period ending December 31, 2025).
How has STERIS gross profit changed year-over-year?
- STERIS (STE) gross profit changed +8.3% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS gross profit?
- STERIS (STE) gross profit compound annual growth rate is +12.7% over the most recent 5 years available.
When did STERIS gross profit hit its highest annual value?
- STERIS gross profit reached its highest annual value of $2.40B in 2025.
What was STERIS gross profit in 2024?
- STERIS (STE) gross profit in 2024 was $2.22B.
What was STERIS gross profit in 2025?
- STERIS (STE) gross profit in 2025 was $2.40B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.